European collaborative research to develop lab-on-chip system for cheap and fast cancer diagnosis


At the Engineering in Medicine and Biology Conference (EMBC) in Buenos Aires (Argentina), imec and its project partners announce the launch of the European Seventh Framework Project MIRACLE. The MIRACLE project aims at developing an operational lab-on-chip for the isolation and detection of circulating and disseminated tumor cells (CTCs and DTCs) in blood. The new lab-on-chip is an essential step towards faster and cost-efficient diagnosis of cancer.

Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps. A full tumor cell detection analysis can take more than a day. A lab-on-chip, integrating the many processing steps, would enable a faster, easy-to-use, cost-effective detection of tumor cells in blood. They are therefore labor-saving and minimally invasive, increasing the patient’s comfort and the efficiency of today’s healthcare.

In a preceding joint project by some of the partners (MASCOT FP6-027652), individual microfluidic modules for cell isolation, cell counting, DNA amplification and detection have been developed. Based on this expertise and strengthened by additional partners, the development of a fully automated, lab-on-chip platform to isolate, count and genotype CTCs is envisaged within the framework of the MIRACLE project. For genotyping, genetic material (i.e. the mRNA) will be extracted from the cells and multiple cancer related markers will be amplified based on multiplex ligation dependent probe amplification (MLPA) followed by their detection using an array of electrochemical sensors. Full integration of all steps requires innovative research and processing steps that need a combination of the multidisciplinary and unique expertise of the different project partners (ranging from microfluidics to interfacing, miniaturization, and integration skills). The resulting lab-on-chip tumor detection system will be well ahead of the current state-of-the-art, revolutionizing cancer diagnostics and individualized theranostics.

Within the framework of the MIRACLE project, imec as project coordinator, collaborates with the Universitat Rovira I Virgili (Spain), the Institut für Mikrotechnik Mainz, AdnaGen, ThinXXs and Consultech (Germany), MRC Holland (The Netherlands), the Oslo University Hospital (Norway), the KTH Royal Institute of Technology, Multi-D and Fujirebio Diagnostics (Sweden), ECCO - the European CanCer Organisation and ICsense (Belgium) and Labman (UK). The project aims at developing a fully automated and integrated microsystem providing the genotype (gene expression profile) of CTCs and DTCs starting from clinical samples. MIRACLE is partly funded by the European Commission (FP7-ICT-2009.3.9).

Facts, background information, dossiers
  • tumor
  • tumor detection
  • theranostics
  • IMEC
  • ict
  • Germany
  • genotyping
  • gene expression
  • Fujirebio Diagnostics
  • European Commission
  • European CanCer Org…
  • ConsulTech
  • cancer diagnostics
  • biology
  • Belgium
  • Argentina
  • AdnaGen
More about AdnaGen
More about thinXXS Microtechnology
More about University of Oslo
  • News

    New model developed to study inflammatory bowel disease in human biopsy samples

    Inflammatory bowel disease (IBD) is a complex condition that requires a lifetime of care and increases a person's cancer risk. But its origins are still a mystery. Now, a team of researchers have created a new culture model of the human intestine where living tissue from a patient biopsy ca ... more

    Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer

    Researchers at VTT Technical Research Centre of Finland, the University of Turku and the University of Oslo have discovered a previously unknown molecular-level mechanism that may partly explain the increased growth of cancer cells. The study, published in the British Journal of Cancer, sho ... more

    Norwegian Team Completes Cod Genome

    Scientist from a consortium of Norwegian marine and aquaculture institutions announced that they have generated the first ever draft sequence and assembly of the Atlantic cod genome. The results, presented at the GenoFisk meeting in Oslo, Norway, include a high-quality genome assembly and p ... more

More about IMEC vzw
More about Royal Institute of Technology
  • News

    The secret life of cells – in colour

    The 2011 Lennart Nilsson Award is to be presented to American biologist Nancy Kedersha, who is to receive the prize for her colour pictures showing the inner life of a cell.The panel’s citation reads as follows: “Nancy Kedersha’s colour images open our eyes to the smallest components of lif ... more

    KTH Royal Institute of Technology: World record in DNA analysis

    To date, scientists have been limited to running a small number of DNA samples at a time at a cost of SEK 100,000 per sample. KTH researchers have now come up with a new method which means that 5,000 samples can be run simultaneously for the same price. This cuts the cost per test result co ... more

More about Fujirebio Diagnostics
More about Labman
More about Universitat Rovira i Virgili
  • News

    New biosensor can detect bacteria instantaneously

    A research group from the Rovira i Virgili University (URV) in Tarragona has developed a biosensor that can immediately detect very low levels of Salmonella typhi , the bacteria that causes typhoid fever. The technique uses carbon nanotubes and synthetic DNA fragments that activate an elect ... more

    Reveal the enemy

    Bacterial diseases are usually detected by first enriching samples, then separating, identifying, and counting the bacteria. This type of procedure usually takes at least two days after arrival of the sample in the laboratory. Tests that work faster, in the field, and without complex sample ... more

More about ECCO
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE